Abstract
Guillain Barré syndrome (GBS) is an acute immune-mediated polyradiculopathy affecting children and adults, which usually presents with acute flaccid paralysis. The association of GBS with vaccination first became a major concern during 1976 when an emerging strain of the influenza virus led to a mass immunization campaign to protect against a potential pandemic. The vaccines were associated with a small but significant increase in the risk of GBS in the weeks following vaccination. In subsequent years, there has been increased monitoring of adverse events relating to influenza vaccines. Assessments conducted following the 1976 influenza vaccination campaign have demonstrated either no risk or a slight elevated risk of GBS following seasonal influenza vaccination (approximately one additional case per million vaccinations). This chapter will discuss the scientific evidence to date regarding the association between influenza vaccines and GBS.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Asbury AK. Guillain-Barré syndrome: historical aspects. Ann Neurol. 1990;27(Suppl):S2–6.
Hughes RA, Cornblath DR. Guillain-Barré syndrome. Lancet. 2005;366(9497):1653–66.
McKhann GM, Cornblath DR, Griffin JW, Ho TW, Li CY, Jiang Z, et al. Acute motor axonal neuropathy: a frequent cause of acute flaccid paralysis in China. Ann Neurol. 1993;33(4):333–42.
Govoni V, Granieri E. Epidemiology of the Guillain-Barré syndrome. Curr Opin Neurol. 2001;14(5):605–13.
McGrogan A, Madle GC, Seaman HE, de Vries CS. The epidemiology of Guillain-Barré syndrome worldwide. A systematic literature review. Neuroepidemiology. 2009;32(2):150–63.
Willison HJ. The immunobiology of Guillain-Barré syndromes. J Peripher Nerv Syst. 2005;10(2):94–112.
Hughes RA, Hadden RD, Gregson NA, Smith KJ. Pathogenesis of Guillain-Barré syndrome. J Neuroimmunol. 1999;100(1–2):74–97.
Sivadon-Tardy V, Orlikowski D, Porcger P, et al. Guillain-Barré syndrome and influenza virus infection. Clin Infect Dis. 2009;48:48–56.
Newton Jr N, Janati A. Guillain-Barré syndrome after vaccination with purified tetanus toxoid. South Med J. 1987;80:1053–4.
Roux X, Gramond C, De Greslan T, et al. Guillain-Barré syndrome and anti-hepatitis A vaccination. Med Mal Infect. 2010;40:490–2.
Kinnunen E, Farkkila M, Hovi T, Juntunen J, Weckstrom P. Incidence of Guillain-Barré syndrome during a nationwide oral poliovirus vaccine campaign. Neurology. 1989;39:1034–6.
Centers for Disease Control and Prevention. Update: GBS among recipients of Menactra meningococcal conjugate vaccine-Unites States, October 2005–February 2006. MMWR Morb Mortal Wkly Rep. 2006;55:364–6.
Schonberger LB, Bregman DJ, Sullivan-Bolyai JZ, et al. Guillain Barré syndrome following vaccination in the national influenza immunization program, United States, 1976–1977. Am J Epidemiol. 1979;110:105–23.
Hutwitz ES, Schoenberger LB, Nelson DB, Holman RC. Guillain Barré syndrome and the 1978–1979 influenza vaccine. N Eng J Med. 1981;304:1557–61.
Kaplan JE, Katona P, Hurwitz ES, Schoenberger LB. Guillain Barré syndrome in the United States, 1979–1980 and 1980–1981. Lack of an association with influenza vaccination. JAMA. 1982;248:698–700.
Kaplan JE, Schoenberger LB, Hurwitz ES, Katona P. Guillain Barré syndrome in the United States, 1978–1981: additional observations from the national surveillance system. Neurology. 1983;33(5):633–7.
Roscelli JD, Bass JW, Pang L. Giuillain Barré syndrome and influenza vaccine in the US Army, 1980–1988. Am J Epidemiol. 1991;133:952–5.
Lasky T, Terracciano GJ, Magder L, Koski CL, Ballesteros M, Nash D, et al. The Guillain Barré syndrome and the 1992–1993 and 1993–1994 influenza vaccines. N Eng J Med. 1998;339:1797–802.
Juurlink DN, Stukel TA, Kwong J, Koop A, Mc Greer A, Upshur RE, et al. Guillain Barré syndrome after influenza vaccination in adults: a population based study. Arch Intern Med. 2006;166:2217–21.
Hughes RA, Charlton J, Latinovic R, Gulliford MC. No association between immunization and Guillain Barré syndrome in the United Kingdom. 1992–2000. Arch Intern Med. 2006;166:1301–4.
Stowe J, Andrews N, Wise L, Miller E. Investigation of the temporal association of Guillain Barré syndrome with influenza vaccine and influenza-like illness using the United Kingdom General Practice database. Am J Epidemiol. 2009;169:382–8.
Haber P, DeStefano F, Angulo F, Iskander FJ, et al. Guillain Barré syndrome following influenza vaccination. JAMA. 2004;292:2478–81.
Centers for Disease Control and Prevention (CDC). Safety of influenza A (H1N1) 2009 monovalent vaccines-United States, October 1–November 24, 2009. MMWR Morb Mortal Wkly Rep. 2009;58(48):1351–6.
Dieleman J, Romio S, Johansen K, Weibel D, et al. Guillain Barré syndrome and adjuvanted pandemic influenza A (H1N1) 2009 vaccine: multinational case-control study in Europe. BMJ. 2011;343:d3908.
Salmon DA, Akhtar A, Mergler MJ, Vannice KS, et al. Immunization-safety monitoring systems for the 2009 H1N1 monovalent influenza vaccination program. Pediatrics. 2011;127 Suppl 1:S78–86.
Centers for Disease Control and Prevention. Preliminary results: surveillance for Guillain Barré syndrome after receipt of influenza A monovalent vaccine-United States, 2009–2010. MMWR Morb Mortal Wkly Rep. 2010;59(61):657.
Velzolli C, Broder KR, Haber P, Guh A, et al. Adverse events following influenza A monovalent vaccines reported to the vaccine adverse events reporting system. United States, October 1, 2009–January 31, 2010. Vaccine. 2010;28:7248–55.
Schattner A. Consequence or coincidence? The occurrence, pathogenesis and significance of autoimmune manifestations after viral vaccines. Vaccine. 2005;23:3876–86.
Sejvar J, Pfeifer D, Schoenberger L. Guillain Barré syndrome following influenza vaccination: causal or coincidental. Curr Infect Dis Rep. 2011;13:387–98.
Brostoff SW, White TM. Absence of P2 protein in swine flu vaccines. JAMA. 1982;247(4):495.
Ziegler DW, Gardner JJ, Warfield DT, Walls HH. Experimental allergic neuritis-like disease in rabbits after injection with influenza vaccines mixed with gangliosides and adjuvants. Infect Immun. 1983;42(2):824–30.
Nachamkin I, Shadomy SV, Moran AP, et al. Anti-ganglioside antibody induction by swine (A/NJ/1976/H1N1) and other influenza vaccines: insights into vaccine-associated Guillain Barré syndrome. J Infect Dis. 2008;198:226–33.
Fiore AE, Uyeki TM, Broder K, et al. Prevention and control of influenza withvaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010. MMWR Recomm Rep. 2010;59:1–62.
Smith NM, Bresee JS, Shay DK, Uyeki TM, Cox NJ, Strikas RA. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2006;55:1–42.
Baxter R, Lewis N, Bakshi N, Vellozzi C, Klein P, CISA Network. Recurrent Guillain-Barré Syndrome following vaccination. Clin Infect Dis. 2012;54(6):800–4.
Acknowledgment
The authors would like to thank Dr. Lawrence B. Schonberger for his valuable contributions to this chapter.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer Science+Business Media New York
About this chapter
Cite this chapter
Bakshi, N., Sejvar, J.J. (2013). Influenza Vaccines and Guillain Barré Syndrome. In: Chatterjee, A. (eds) Vaccinophobia and Vaccine Controversies of the 21st Century. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-7438-8_17
Download citation
DOI: https://doi.org/10.1007/978-1-4614-7438-8_17
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4614-7437-1
Online ISBN: 978-1-4614-7438-8
eBook Packages: MedicineMedicine (R0)